This Is the Best ETF of the Past 10 Years
What happens when a smart-beta strategy meets an industry rife with M&A? You get a 420% return.
This article is for subscribers only.
America doesn’t run on Dunkin', it runs on drugs. Just look at the best-performing exchange-traded funds of the past decade.
Topping them all, in any sector, industry, or country, is the PowerShares Dynamic Pharmaceuticals Portfolio (PJP), up 420 percent over the past 10 years. A pair of biotech ETFs are a distant second and third. Here are the leading ETFs, their 10-year returns, and their total assets in millions of dollars.